186 related articles for article (PubMed ID: 31582311)
1. Energy level and fatigue after surgery for thyroid cancer: A population-based study of patient-reported outcomes.
Hughes DT; Reyes-Gastelum D; Kovatch KJ; Hamilton AS; Ward KC; Haymart MR
Surgery; 2020 Jan; 167(1):102-109. PubMed ID: 31582311
[TBL] [Abstract][Full Text] [Related]
2. INITIAL ADOPTION OF RECOMBINANT HUMAN THYROID-STIMULATING HORMONE FOLLOWING THYROIDECTOMY IN THE MEDICARE THYROID CANCER PATIENT POPULATION.
Dinan MA; Li Y; Reed SD; Sosa JA
Endocr Pract; 2019 Jan; 25(1):31-42. PubMed ID: 30383499
[TBL] [Abstract][Full Text] [Related]
3. Extent of surgery for low-risk thyroid cancer in the elderly: Equipoise in survival but not in short-term outcomes.
Zambeli-Ljepović A; Wang F; Dinan MA; Hyslop T; Stang MT; Roman SA; Sosa JA; Scheri RP
Surgery; 2019 Nov; 166(5):895-900. PubMed ID: 31288935
[TBL] [Abstract][Full Text] [Related]
4. Use of imaging tests after primary treatment of thyroid cancer in the United States: population based retrospective cohort study evaluating death and recurrence.
Banerjee M; Wiebel JL; Guo C; Gay B; Haymart MR
BMJ; 2016 Jul; 354():i3839. PubMed ID: 27443325
[TBL] [Abstract][Full Text] [Related]
5. Patient-Perceived Lack of Choice in Receipt of Radioactive Iodine for Treatment of Differentiated Thyroid Cancer.
Wallner LP; Reyes-Gastelum D; Hamilton AS; Ward KC; Hawley ST; Haymart MR
J Clin Oncol; 2019 Aug; 37(24):2152-2161. PubMed ID: 31283406
[TBL] [Abstract][Full Text] [Related]
6. Multilevel Factors Associated With More Intensive Use of Radioactive Iodine for Low-Risk Thyroid Cancer.
Wallner LP; Banerjee M; Reyes-Gastelum D; Hamilton AS; Ward KC; Lubitz C; Hawley ST; Haymart MR
J Clin Endocrinol Metab; 2021 May; 106(6):e2402-e2412. PubMed ID: 33687063
[TBL] [Abstract][Full Text] [Related]
7. Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial.
Dehbi HM; Mallick U; Wadsley J; Newbold K; Harmer C; Hackshaw A
Lancet Diabetes Endocrinol; 2019 Jan; 7(1):44-51. PubMed ID: 30501974
[TBL] [Abstract][Full Text] [Related]
8. Association Between Pregnancy Outcomes and Radioactive Iodine Treatment After Thyroidectomy Among Women With Thyroid Cancer.
Kim HO; Lee K; Lee SM; Seo GH
JAMA Intern Med; 2020 Jan; 180(1):54-61. PubMed ID: 31633736
[TBL] [Abstract][Full Text] [Related]
9. Post-thyroidectomy neck appearance and impact on quality of life in thyroid cancer survivors.
Kurumety SK; Helenowski IB; Goswami S; Peipert BJ; Yount SE; Sturgeon C
Surgery; 2019 Jun; 165(6):1217-1221. PubMed ID: 31030973
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for hypocalcaemia after completion hemithyroidectomy in thyroid cancer.
Aqtashi B; Ahmad N; Frotzler A; Bähler S; Linder T; Müller W
Swiss Med Wkly; 2017; 147():w14513. PubMed ID: 29120026
[TBL] [Abstract][Full Text] [Related]
11. Association of adjuvant radioactive iodine therapy with survival in node-positive papillary thyroid cancer.
Sun Y; Gong J; Guo B; Shang J; Cheng Y; Xu H
Oral Oncol; 2018 Dec; 87():152-157. PubMed ID: 30527231
[TBL] [Abstract][Full Text] [Related]
12. Treatment Variation in Older Adults With Differentiated Thyroid Cancer.
Sutton W; Canner JK; Segev DL; Zeiger MA; Mathur A
J Surg Res; 2020 Oct; 254():154-164. PubMed ID: 32445931
[TBL] [Abstract][Full Text] [Related]
13. Clinical predictors of quality of life in patients with initial differentiated thyroid cancers.
Almeida JP; Vartanian JG; Kowalski LP
Arch Otolaryngol Head Neck Surg; 2009 Apr; 135(4):342-6. PubMed ID: 19380354
[TBL] [Abstract][Full Text] [Related]
14. Population-Based Assessment of Complications Following Surgery for Thyroid Cancer.
Papaleontiou M; Hughes DT; Guo C; Banerjee M; Haymart MR
J Clin Endocrinol Metab; 2017 Jul; 102(7):2543-2551. PubMed ID: 28460061
[TBL] [Abstract][Full Text] [Related]
15. An Exploratory Study of Fatigue and Physical Activity in Canadian Thyroid Cancer Patients.
Alhashemi A; Jones JM; Goldstein DP; Mina DS; Thabane L; Sabiston CM; Chang EK; Brierley JD; Sawka AM
Thyroid; 2017 Sep; 27(9):1156-1163. PubMed ID: 28712348
[TBL] [Abstract][Full Text] [Related]
16. Postoperative radioactive iodine-131 ablation is not necessary among patients with intermediate-risk differentiated thyroid carcinoma: a population-based study.
Zhang H; Cai Y; Zheng L; Zhang Z; Jiang N
Hell J Nucl Med; 2017; 20(1):3-10. PubMed ID: 28315902
[TBL] [Abstract][Full Text] [Related]
17. Effect of radioiodine therapy under thyroid hormone withdrawal on health-related quality of life in patients with differentiated thyroid cancer.
Ming H; Yu H; Liu Y; Yang L; Chen Y
Jpn J Clin Oncol; 2022 Oct; 52(10):1159-1166. PubMed ID: 35848939
[TBL] [Abstract][Full Text] [Related]
18. Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer.
Ruel E; Thomas S; Dinan MA; Perkins JM; Roman SA; Sosa JA
Endocrine; 2016 Jun; 52(3):579-86. PubMed ID: 26708045
[TBL] [Abstract][Full Text] [Related]
19. Association of Preoperative Anemia With 30-Day Morbidity and Mortality Among Patients With Thyroid Cancer Who Undergo Thyroidectomy.
Burton BN; Okwuegbuna O; Jafari A; Califano J; Brumund KT; Gabriel RA
JAMA Otolaryngol Head Neck Surg; 2019 Feb; 145(2):124-131. PubMed ID: 30489623
[TBL] [Abstract][Full Text] [Related]
20. Predictors of Neck Reoperation and Mortality After Initial Total Thyroidectomy for Differentiated Thyroid Cancer.
Semrad TJ; Keegan THM; Semrad A; Brunson A; Farwell DG
Thyroid; 2018 Sep; 28(9):1143-1152. PubMed ID: 29929451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
